Brian L. West

Active 1983–2024

78
Papers
26,924
Citations
70
h-index
76
i10-index

Citations

Citations per year for Brian L. West1961: 1 citations1984: 4 citations1985: 12 citations1986: 23 citations1987: 39 citations1988: 58 citations1989: 53 citations1990: 56 citations1991: 61 citations1992: 45 citations1993: 49 citations1994: 36 citations1995: 39 citations1996: 42 citations1997: 61 citations1998: 87 citations1999: 87 citations2000: 102 citations2001: 92 citations2002: 79 citations2003: 81 citations2004: 51 citations2005: 55 citations2006: 49 citations2007: 76 citations2008: 65 citations2009: 71 citations2010: 120 citations2011: 163 citations2012: 221 citations2013: 284 citations2014: 254 citations2015: 340 citations2016: 435 citations2017: 521 citations2018: 602 citations2019: 1,192 citations2020: 1,470 citations2021: 1,577 citations2022: 1,129 citations2023: 853 citations2024: 1,180 citations2025: 618 citations2026: 25 citations1962–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,439 citing papers, 34.2% of this breakdownChina: 1,476 citing papers, 11.4% of this breakdownGermany: 733 citing papers, 5.6% of this breakdownUnited Kingdom: 720 citing papers, 5.5% of this breakdownFrance: 537 citing papers, 4.1% of this breakdownItaly: 490 citing papers, 3.8% of this breakdownCanada: 387 citing papers, 3% of this breakdownJapan: 373 citing papers, 2.9% of this breakdownAustralia: 372 citing papers, 2.9% of this breakdownNetherlands: 318 citing papers, 2.5% of this breakdownSwitzerland: 316 citing papers, 2.4% of this breakdownSpain: 289 citing papers, 2.2% of this breakdown
0%34.2%Other 19.5%

Fields

  • Medicine31.4%
  • Biochemistry, Genetics and Molecular Biology28.7%
  • Neuroscience20.8%
  • Immunology and Microbiology14.7%
  • Computer Science1.6%
  • Engineering0.7%
  • Other2.1%

Topics

  • Neuroinflammation and Neurodegeneration Mechanisms7.9%
  • Immune cells in cancer7.9%
  • Cancer Immunotherapy and Biomarkers3.9%
  • Melanoma and MAPK Pathways2.8%
  • Immunotherapy and Immune Responses2%
  • Immune Cell Function and Interaction1.9%
  • Other73.6%

Coauthors

All papers

Open in search
  1. Colony-Stimulating Factor 1 Receptor Signaling Is Necessary for Microglia Viability, Unmasking a Microglia Progenitor Cell in the Adult Brain

    Authors: , , , , , , , , , , - Neuron 2014 cited by 2,030

  2. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2019 cited by 998

  3. CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models

    Authors: , , , , , , , , , - Cancer Research 2014 cited by 1,287

  4. Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

    Authors: , , , , , , , , , , , , , , , , , - Neuro-Oncology 2015 cited by 580

  5. Eliminating microglia in Alzheimer’s mice prevents neuronal loss without modulating amyloid-β pathology

    Authors: , , , , , , , - Brain 2016 cited by 737

  6. Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy

    Authors: , , , , , , , , , , , , , , - Cancer Discovery 2011 cited by 1,718

  7. Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses

    Authors: , , , , , , , , , , , , , , , , , , - Cancer Research 2012 cited by 941

  8. Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke

    Authors: , , , , , , , , , , , - Nature Communications 2016 cited by 587

  9. Microglia modulate blood flow, neurovascular coupling, and hypoperfusion via purinergic actions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2022 cited by 268

  10. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Igor Puzanov, Kevin B. Kim, Antoni Ribas, Grant A. McArthur, Jeffrey A. Sosman, Paul B. Chapman, Keith T. Flaherty, Xiaowei Xu, Katherine L. Nathanson, K. B. Nolop - Nature 2010 cited by 1,837

  11. Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , C. M. Gee, Brian L. West, Peter Hirth, K. B. Nolop, Matt van de Rijn, Henry H. Hsu, Charles Peterfy, Paul Lin, Sandra Tong-Starksen, Gideon Bollag - New England Journal of Medicine 2015 cited by 582

  12. CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer

    Authors: , , , , , , , , - Cancer Research 2013 cited by 561

  13. Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice

    Authors: , , , , , , , - Journal of Neuroinflammation 2015 cited by 525

  14. Replacement of microglia in the aged brain reverses cognitive, synaptic, and neuronal deficits in mice

    Authors: , , , , , , , , , , - Aging Cell 2018 cited by 394

  15. Microglial Stimulation of Glioblastoma Invasion Involves Epidermal Growth Factor Receptor (EGFR) and Colony Stimulating Factor 1 Receptor (CSF-1R) Signaling

    Authors: , , , , , , - Molecular Medicine 2012 cited by 443

  16. Activated microglia drive demyelination via CSF1R signaling

    Authors: , , , , , - Glia 2021 cited by 152

  17. Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ben Powell, Gaston Habets, Chao Zhang, Prabha N. Ibrahim, Peter Hirth, Dean R. Artis, Meenhard Herlyn, Gideon Bollag - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 1,346

  18. Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation

    Authors: , , , , , , , , , , , , , , - Nature Genetics 2014 cited by 510

  19. Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors

    Authors: , , , , , , , , , , , , - Therapeutic Advances in Medical Oncology 2019 cited by 169

  20. Inhibition of CSF-1 Receptor Improves the Antitumor Efficacy of Adoptive Cell Transfer Immunotherapy

    Authors: , , , , , , , , , - Cancer Research 2013 cited by 318

  21. Microglial repopulation resolves inflammation and promotes brain recovery after injury

    Authors: , , , , , - Glia 2017 cited by 230

  22. Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas

    Authors: , , , , , , - Oncogene 2017 cited by 248

  23. Elimination of microglia improves cognitive function following cranial irradiation

    Authors: , , , , , , , , , , , , - Scientific Reports 2016 cited by 270

  24. Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Investigation 2011 cited by 387